Research in Social and Administrative Pharmacy
Volume 6, Issue 3 , Pages 185-195 , September 2010

Receiving a pharmaceutical care service compared to receiving standard pharmacy service in Sweden–How do patients differ with regard to perceptions of medicine use and the pharmacy encounter?

  • Anna T. Montgomery, M.Sc. (Pharm.)

      Affiliations

    • Department of Pharmacy, Uppsala University, Uppsala, Sweden
    • Apoteket AB, Stockholm, Sweden
    • Corresponding Author InformationCorresponding author. Apoteket AB, SE-118 81 Stockholm, Sweden. Tel.: +46-10-447-52-27; fax: +469-10-447-50-80.
  • ,
  • Sofia Kälvemark Sporrong, Ph.D.

      Affiliations

    • Department of Pharmacy, Uppsala University, Uppsala, Sweden
    • Apoteket AB, Stockholm, Sweden
    • Department of Public Health and Caring Sciences, Uppsala University, Uppsala, Sweden
  • ,
  • Nila Manap, M.Sc. (Pharm.)

      Affiliations

    • Apoteket AB, Stockholm, Sweden
  • ,
  • Mary P. Tully, Ph.D.

      Affiliations

    • Department of Pharmacy, Uppsala University, Uppsala, Sweden
    • School of Pharmacy and Pharmaceutical Sciences, University of Manchester, Manchester, UK
  • ,
  • Åsa Kettis Lindblad, Ph.D.

      Affiliations

    • Department of Pharmacy, Uppsala University, Uppsala, Sweden
    • Quality and Evaluation Unit, Uppsala University, Uppsala, Sweden

References 

  1. Pirmohamed M, James S, Meakin S, et al. Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients. BMJ. 2004;329:15–19
  2. Cipolle RJ, Strand LM, Moreley PC. Pharmaceutical Care Practice—The Clinician's Guide. 2nd ed.. New York, NY: McGraw-Hill Companies, Inc; 2004;
  3. Hepler CD, Strand LM. Opportunities and responsibilities in pharmaceutical care. Am J Hosp Pharm. 1990;47:533–543
  4. International Pharmaceutical Federation . FIP statement of professional standards—pharmaceutical care, 1998. Available at: http://www.fip.orgAccessed 27.02.2009
  5. Pharmaceutical Care Network Europe . PCNE Mission Statement. Available at: http://www.pcne.orgAccessed 27.02.2009
  6. McGivney MS, Meyer SM, Duncan-Hewitt W, Hall DL, Goode JV, Smith RB. Medication therapy management: its relationship to patient counseling, disease management, and pharmaceutical care. J Am Pharm Assoc (2003). 2007;47:620–628
  7. Mangiapane S, Schulz M, Muhlig S, Ihle P, Schubert I, Waldmann HC. Community pharmacy-based pharmaceutical care for asthma patients. Ann Pharmacother. 2005;39:1817–1822
  8. Herborg H, Soendergaard B, Froekjaer B, et al. Improving drug therapy for patients with asthma—part 1: Patient outcomes. J Am Pharm Assoc (Wash). 2001;41:531–550
  9. Vrijens B, Belmans A, Matthys K, de Klerk E, Lesaffre E. Effect of intervention through a pharmaceutical care program on patient adherence with prescribed once-daily atorvastatin. Pharmacoepidemiol Drug Saf. 2006;15:115–121
  10. Tsuyuki RT, Johnson JA, Teo KK, et al. A randomized trial of the effect of community pharmacist intervention on cholesterol risk management: the Study of Cardiovascular Risk Intervention by Pharmacists (SCRIP). Arch Intern Med. 2002;162:1149–1155
  11. Krass I, Armour CL, Mitchell B, et al. The Pharmacy Diabetes Care Program: assessment of a community pharmacy diabetes service model in Australia. Diabet Med. 2007;24:677–683
  12. Benrimoj SI, Peacocke G, Whitehead P, Kopecny E, Ward PR, Emerson L. Cognitive pharmaceutical services in emerging health care systems—new patient medication management and concordance services in community pharmacy. J Soc Adm Pharm. 2003;20:2–11
  13. Bernsten C, Bjorkman I, Caramona M, et al. Improving the well-being of elderly patients via community pharmacy-based provision of pharmaceutical care: a multicentre study in seven European countries. Drugs Aging. 2001;18:63–77
  14. Sturgess IK, McElnay JC, Hughes CM, Crealey G. Community pharmacy based provision of pharmaceutical care to older patients. Pharm World Sci. 2003;25:218–226
  15. Volume CI, Farris KB, Kassam R, Cox CE, Cave A. Pharmaceutical care research and education project: patient outcomes. J Am Pharm Assoc (Wash). 2001;41:411–420
  16. Montgomery AT, Kalvemark-Sporrong S, Tully MP, Kettis-Lindblad A. Follow-up of patients receiving a pharmaceutical care service in Sweden. J Clin Pharm Ther. 2008;33:653–662
  17. Renberg T, Kettis-Lindblad A, Tully MP. Exploring subjective outcomes perceived by patients receiving a pharmaceutical care service. Res Soc Adm Pharm. 2006;2:212–231
  18. Narhi U, Airaksinen M, Tanskanen P, Enlund H. The effects of a pharmacy-based intervention on the knowledge and attitudes of asthma patients. Patient Educ Couns. 2001;43:171–177
  19. Lindley CM, Tully MP, Paramsothy V, Tallis RC. Inappropriate medication is a major cause of adverse drug reactions in elderly patients. Age Ageing. 1992;21:294–300
  20. Brooks JM, Unni EJ, Klepser DG, Urmie JM, Farris KB, Doucette WR. Factors affecting demand among older adults for medication therapy management services. Res Soc Adm Pharm. 2008;4:309–319
  21. Apoteket AB. [Utblicken, kundenkät] Survey for pharmacy clients; 2007.
  22. Horne R, Weinman J, Hankins M. The beliefs about medicines questionnaire: the development and evaluation of a new method for assessing the cognitive representation of medication. Psychol Health. 1999;14:1–24
  23. Morisky DE, Ang A, Krousel-Wood M, Ward HJ. Predictive validity of a medication adherence measure in an outpatient setting. J Clin Hypertens. 2008;10:348–354
  24. Ware JE, Sherbourne CD. The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection. Med Care. 1992;30:473–483
  25. Westerlund LT, Almarsdottir AB, Melander A. Drug-related problems and pharmacy interventions in community pharmacy. Int J Pharm Pract. 1999;7:40–50
  26. Manap N. Utvärdering av en farmaceutisk rådgivningstjänst på apotek—Pilottest av patientenkät [Evaluation of a pharmaceutical care service in communiyt pharmacy—Pilot test of a patient survey]. [undergraduate thesis]. Uppsala, Sweden: Faculty of Pharmacy, Uppsala University, 2008.
  27. Sodergard B, Halvarsson M, Lindback S, Sonnerborg A, Tully MP, Lindblad AK. Differences in adherence and motivation to HIV therapy—two independent assessments in 1998 and 2002. Pharm World Sci. 2006;28:248–256
  28. Granas AG, Bates I. Patients' understanding and management of their illnesses and prescribed medicines—a descriptive study. Pharm World Sci. 2005;27:321–328
  29. Street RL, Makoul G, Arora NK, Epstein RM. How does communication heal? Pathways linking clinician-patient communication to health outcomes. Patient Educ Couns. 2009;74:295–301
  30. Gatti ME, Jacobson KL, Gazmararian JA, Schmotzer B, Kripalani S. Relationships between beliefs about medications and adherence. Am J Health Syst Pharm. 2009;66:657–664
  31. Mann DM, Ponieman D, Leventhal H, Halm EA. Predictors of adherence to diabetes medications: the role of disease and medication beliefs. J Behav Med. 2009;32:278–284
  32. Wright EC. Non-compliance—or how many aunts has Matilda?. Lancet. 1993;342:909–913

PII: S1551-7411(09)00107-7

doi: 10.1016/j.sapharm.2009.09.002

Research in Social and Administrative Pharmacy
Volume 6, Issue 3 , Pages 185-195 , September 2010